Personal information

Websites & social links

https://www.samsph.com/edu_subject/2019/WPe9Q3eL.html

Keywords

Clinical pharmacy, Hospital pharmacy, pharmacogenomics, Biomedical engineering

Countries

China

Activities

Collapse all

Employment (3)

University of Electronic Science and Technology of China: Chengdu, CN

Post Doctoral/Doctoral / Master Supervisor ( School of Medicine)
Employment
Source: Self-asserted source
Rongsheng Tong

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital: Chengdu, Sichuan, CN

Director (Department of Pharmacy)
Employment
Source: Self-asserted source
Rongsheng Tong

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital: Chengdu, Sichuan, CN

Director (Personalized Drug Therapy Key Laboratory of Sichuan Province)
Employment
Source: Self-asserted source
Rongsheng Tong

Education and qualifications (2)

Chengdu University of Traditional Chinese Medicine: Chengdu, Sichuan, CN

2007-09 to 2010-07 | Doctor of Chinese pharmacy (school of Pharmacy)
Education
Source: Self-asserted source
Rongsheng Tong

West China University of Medical Sciences: Chengdu, Sichuan, CN

1992-09 to 1995-07 | Master of Pharmacology (school of Pharmacy)
Education
Source: Self-asserted source
Rongsheng Tong

Professional activities (3)

Chinese Pharmaceutical Association: Beijing, CN

Vice chairman (clinical evaluation and Research Committee)
Membership
Source: Self-asserted source
Rongsheng Tong

Chinese Medical Association clinicl pharmacy branch: Zhengzhou , henan, CN

Chairman-elect
Membership
Source: Self-asserted source
Rongsheng Tong

Chinese Medical Association Sichuan Branch : Chengdu, Sichuan, CN

Chairman (Clinical Pharmacy Committee)
Membership
Source: Self-asserted source
Rongsheng Tong

Funding (2)

Clinical value oriented personalized new drug development and evaluation platform integrating key technologies such as artificial intelligence and gene editing

Grant
Science and Technology Department in Sichuan province (Chengdu, Sichuan, CN)
GRANT_NUMBER:

2019YFS0514
Source: Self-asserted source
Rongsheng Tong

Demonstration of construction and integrated application of polypharmacy management system for the elderly with common diseases

Grant
Ministry of Science and Technology (Peking, CN)
GRANT_NUMBER:

2020YFC2005500
Source: Self-asserted source
Rongsheng Tong

Works (21)

Diagnosis Test Meta-Analysis for Apolipoprotein E in Alzheimer's Disease.

Disease markers
2020-10-09 | Journal article
DOI: 10.1155/2020/6486031
PMID: 33101544
PMC: PMC7569444
Source: Self-asserted source
Rongsheng Tong

Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials.

Signal transduction and targeted therapy
2020-09-23 | Journal article
DOI: 10.1038/s41392-020-00315-3
PMID: 32968059
PMC: PMC7511340
Source: Self-asserted source
Rongsheng Tong

Efficient Colorectal Cancer Gene Therapy with IL-15 mRNA Nanoformulation.

Molecular pharmaceutics
2020-08-27 | Journal article
DOI: 10.1021/acs.molpharmaceut.0c00451
PMID: 32787272
Source: Self-asserted source
Rongsheng Tong

Predictive models of medication non-adherence risks of patients with T2D based on multiple machine learning algorithms.

BMJ open diabetes research & care
2020-03-01 | Journal article
DOI: 10.1136/bmjdrc-2019-001055
PMID: 32156739
PMC: PMC7064141
Source: Self-asserted source
Rongsheng Tong

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.

Drug design, development and therapy
2019-12-19 | Journal article
DOI: 10.2147/dddt.s211665
PMID: 31908417
PMC: PMC6930838
Source: Self-asserted source
Rongsheng Tong

Erenumab safety and efficacy in migraine: A systematic review and meta-analysis of randomized clinical trials.

Medicine
2019-12-01 | Journal article
DOI: 10.1097/md.0000000000018483
PMID: 31876735
PMC: PMC6946432
Source: Self-asserted source
Rongsheng Tong

A concise review of recent advances in anti-heart failure targets and its small molecules inhibitors in recent years.

European journal of medicinal chemistry
2019-11-14 | Journal article
DOI: 10.1016/j.ejmech.2019.111852
PMID: 31759729
Source: Self-asserted source
Rongsheng Tong

RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review).

International journal of molecular medicine
2019-06-14 | Journal article
DOI: 10.3892/ijmm.2019.4244
PMID: 31198981
PMC: PMC6658002
Source: Self-asserted source
Rongsheng Tong

The association of the PCSK9 rs562556 polymorphism with serum lipids level: a meta-analysis.

Lipids in health and disease
2019-04-30 | Journal article
DOI: 10.1186/s12944-019-1036-1
PMID: 31036026
PMC: PMC6489332
Source: Self-asserted source
Rongsheng Tong

Mechanism of penehyclidine hydrochloride on a dysmenorrhea rat model.

Drug development research
2018-12-03 | Journal article
DOI: 10.1002/ddr.21500
PMID: 30511353
Source: Self-asserted source
Rongsheng Tong

Anti-neoplastic effect of mangiferin on human ovarian adenocarcinoma OVCAR8 cells via the regulation of YAP.

Oncology letters
2018-11-15 | Journal article
DOI: 10.3892/ol.2018.9708
PMID: 30655860
PMC: PMC6313056
Source: Self-asserted source
Rongsheng Tong

Mangiferin: An effective therapeutic agent against several disorders (Review).

Molecular medicine reports
2018-10-02 | Journal article
DOI: 10.3892/mmr.2018.9529
PMID: 30280187
Source: Self-asserted source
Rongsheng Tong

Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining.

Oncology reports
2018-10-01 | Journal article
DOI: 10.3892/or.2018.6756
PMID: 30272350
Source: Self-asserted source
Rongsheng Tong

Multidimensional Theranostics for Tumor Fluorescence Imaging, Photoacoustic Imaging and Photothermal Treatment Based on Manganese Doped Carbon Dots.

Journal of biomedical nanotechnology
2018-09-01 | Journal article
DOI: 10.1166/jbn.2018.2565
PMID: 29958553
Source: Self-asserted source
Rongsheng Tong

The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis.

Hematology (Amsterdam, Netherlands)
2018-07-19 | Journal article
DOI: 10.1080/10245332.2018.1500750
PMID: 30024839
Source: Self-asserted source
Rongsheng Tong

Multifaceted regulation and functions of YAP/TAZ in tumors (Review).

Oncology reports
2018-05-08 | Journal article
DOI: 10.3892/or.2018.6423
PMID: 29749524
PMC: PMC6059739
Source: Self-asserted source
Rongsheng Tong

Mangiferin induces islet regeneration in aged mice through regulating p16INK4a.

International journal of molecular medicine
2018-03-01 | Journal article
DOI: 10.3892/ijmm.2018.3524
PMID: 29512742
PMC: PMC5881804
Source: Self-asserted source
Rongsheng Tong
grade
Preferred source (of 2)‎

PKM2 in carcinogenesis and oncotherapy.

Oncotarget
2017-11-20 | Journal article
DOI: 10.18632/oncotarget.22529
PMID: 29299177
PMC: PMC5746412
Source: Self-asserted source
Rongsheng Tong

Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one Derivatives.

Molecules (Basel, Switzerland)
2016-04-20 | Journal article
DOI: 10.3390/molecules21040516
PMID: 27104509
PMC: PMC6273811
Source: Self-asserted source
Rongsheng Tong

Rapid and sensitive headspace gas chromatography-mass spectrometry method for the analysis of ethanol in the whole blood.

Journal of clinical laboratory analysis
2014-03-19 | Journal article
DOI: 10.1002/jcla.21698
PMID: 24648310
PMC: PMC6807615
Source: Self-asserted source
Rongsheng Tong

A promising approach for asthma treatment by multiwayly modulating toll-like receptors.

European review for medical and pharmacological sciences
2012-12-01 | Journal article
PMID: 23280024
Source: Self-asserted source
Rongsheng Tong
How many people are using ORCID?